Reactions Weekly

, Volume 1688, Issue 1, pp 7–7 | Cite as

ACYP2 variant associated with cisplatin-induced hearing loss

Clinical study


  1. Drogemoller BI, et al. Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients. Clinical cancer research: an official journal of the American Association for Cancer Research : 22 Jan 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations